61
Participants
Start Date
July 31, 2013
Primary Completion Date
July 31, 2015
Study Completion Date
December 31, 2015
Budesonide
Subjects will receive the standard aerosolized dose of budesonide (0.5 mg).
Placebo
Aerosolized normal saline will be prepared to mimic the intervention arm, with the quantity, appearance and timing of the doses the being the same.
Formoterol
Subjects will receive the standard aerosolized dose of formoterol (20 mcg) .
Mayo Clinic in Florida, Jacksonville
Mayo Clinic in Rochester, Rochester
University of Arizona, Tucson
Stanford University, Stanford
Beth Israel Medical Center, Boston
Lead Sponsor
Stanford University
OTHER
Beth Israel Deaconess Medical Center
OTHER
University of Arizona
OTHER
National Center for Research Resources (NCRR)
NIH
Mayo Clinic
OTHER